News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Interferon Beta DNA Treatment Delivered with Ichor Medical Systems, Inc. Technology Reduces Atherosclerosis Progression in Mice
March 27, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW ORLEANS--(BUSINESS WIRE)--Summary: Proprietary DNA delivery technology enables sustained Interferon-beta production from muscle cells – reduces atherosclerosis progression in mouse model of heart disease
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
MORE ON THIS TOPIC
FDA
Are Animals Out? How NAMs Are Changing the Rules of the Game
November 26, 2025
·
7 min read
·
BioSpace Insights
Obesity
Novo Bounces Back With ‘Competitive’ Mid-Stage Weight Loss Data for Amycretin
November 25, 2025
·
2 min read
·
Tristan Manalac
Cancer
ASH25: Late-Stage Data For J&J’s Tecvayli/Darzalex Combo Could ‘Shift Paradigm’ in Myeloma
November 25, 2025
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
J&J’s Anti-Tau Bet Falls Flat in Mid-Stage Alzheimer’s Trial
November 24, 2025
·
1 min read
·
Heather McKenzie